Philadelphia Pharmaceuticals Company (ASE:PHIL)
2.000
+0.010 (0.50%)
At close: Jul 30, 2026
36.05% (1Y)
| Market Cap | 15.00M +36.1% |
| Revenue (ttm) | 8.97M -2.3% |
| Net Income | 1.06M +15.9% |
| EPS | 0.14 +15.9% |
| Shares Out | 7.50M |
| PE Ratio | 14.15 |
| Forward PE | n/a |
| Dividend | 0.07 (3.50%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | 2 |
| Open | 2.000 |
| Previous Close | 1.990 |
| Day's Range | 2.000 - 2.000 |
| 52-Week Range | 1.460 - 2.010 |
| Beta | 0.04 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |